The Valley Desk

NCT06850922 · Interventional trial

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603 Administered Alone or in Combination With Aflibercept or Faricimab in Participants With Diabetic Macular Edema

Overall registry status Completed

Phase 1 · Phase 2

Conditions Diabetic Macular Edema

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov